?:definition
|
-
In utero exposure of an embryo/foetus to a medicinal product administered to the pregnant mother. Comment: This term is not intended to describe an authorised route of administration for use in marketing authorisations, and does not cover intentional administration of a medicinal product to an embryo/foetus. It is intended for use in adverse event reporting for pharmacovigilance purposes.
|